Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · IEX Real-Time Price · USD

3.170

+0.230 (7.82%)

At close: Jul 2, 2024, 4:00 PM

3.090

-0.080 (-2.52%)

After-hours: Jul 2, 2024, 4:24 PM EDT

Tenax Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2000
Net Income	-7.71	-11.05	-32.47	-9.85	-8.39	Upgrade
Depreciation & Amortization	0.01	0.11	0.11	0.11	0.11	Upgrade
Share-Based Compensation	0.19	0.37	0.77	0.35	0.27	Upgrade
Other Operating Activities	1.61	-0.82	20.74	0.11	0.46	Upgrade
Operating Cash Flow	-5.9	-11.39	-10.86	-9.27	-7.56	Upgrade
Capital Expenditures	0	-0	-0.01	-0	-0	Upgrade
Change in Investments	0	0	0.46	0.02	0	Upgrade
Investing Cash Flow	0	-0	0.45	0.02	-0	Upgrade
Share Issuance / Repurchase	14.19	7.93	9.74	10.35	0.1	Upgrade
Debt Issued / Paid	-0.62	0	0	0.24	0	Upgrade
Financing Cash Flow	13.57	7.93	9.74	10.6	0.1	Upgrade
Net Cash Flow	7.67	-3.46	-0.67	1.34	-7.46	Upgrade
Free Cash Flow	-5.9	-11.39	-10.86	-9.28	-7.56	Upgrade
Free Cash Flow Per Share	-23.75	-619.37	-844.54	-1431.84	-1952.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).